105 related articles for article (PubMed ID: 2157785)
1. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
[TBL] [Abstract][Full Text] [Related]
2. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.
Rankin JA; Sylvester I; Smith S; Yoshimura T; Leonard EJ
J Clin Invest; 1990 Nov; 86(5):1556-64. PubMed ID: 2173722
[TBL] [Abstract][Full Text] [Related]
3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
4. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
5. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
Sato E; Koyama S; Nomura H; Kubo K; Sekiguchi M
J Immunol; 1996 Oct; 157(7):3122-9. PubMed ID: 8816423
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke.
Tardif J; Borgeat P; Laviolette M
Am J Respir Cell Mol Biol; 1990 Feb; 2(2):155-61. PubMed ID: 2155016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages exposed to particulate and soluble stimuli.
Bertram TA; Overby LH; Brody AR; Eling TE
Lab Invest; 1989 Oct; 61(4):457-66. PubMed ID: 2552225
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral N-acetylcysteine on cell content and macrophage function in bronchoalveolar lavage from healthy smokers.
Linden M; Wieslander E; Eklund A; Larsson K; Brattsand R
Eur Respir J; 1988 Jul; 1(7):645-50. PubMed ID: 2846345
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alveolar macrophage production of chemoattractants by leukotriene B4 and prostaglandin E2.
Christman JW; Christman BW; Shepherd VL; Rinaldo JE
Am J Respir Cell Mol Biol; 1991 Sep; 5(3):297-304. PubMed ID: 1654953
[TBL] [Abstract][Full Text] [Related]
13. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
Wieslander E; Linden M; Håkansson L; Eklund A; Blaschke E; Brattsand R; Venge P
Eur J Respir Dis; 1987 Oct; 71(4):263-72. PubMed ID: 2826202
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of arachidonic acid in human alveolar macrophages from patients with sarcoidosis.
De Rose V; Crivellari MT; Viganò T; Folco GC; Trentin L; Masciarelli M; Semenzato G; Pozzi E; Gialdroni Grassi G
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():445-8. PubMed ID: 1847782
[No Abstract] [Full Text] [Related]
15. Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium.
Damon M; Chavis C; Daures JP; Crastes de Paulet A; Michel FB; Godard P
Eur Respir J; 1989 Mar; 2(3):202-9. PubMed ID: 2543595
[TBL] [Abstract][Full Text] [Related]
16. Zymosan enhances leukotriene D4 metabolism by porcine alveolar macrophages.
Paterson NA; McIver DJ; Schurch S
Immunology; 1985 Sep; 56(1):153-9. PubMed ID: 3930390
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of human neutrophil and alveolar macrophage LTB4 production by N-acetylcysteine: role of hydrogen peroxide.
Dent G; Rabe KF; Magnussen H
Br J Pharmacol; 1997 Oct; 122(4):758-64. PubMed ID: 9375974
[TBL] [Abstract][Full Text] [Related]
18. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis.
De Rose V; Trentin L; Crivellari MT; Cipriani A; Gialdroni Grassi G; Pozzi E; Folco G; Semenzato G
Thorax; 1997 Jan; 52(1):76-83. PubMed ID: 9039241
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages.
Peters-Golden M; Thebert P
Am Rev Respir Dis; 1987 May; 135(5):1020-6. PubMed ID: 3034108
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung.
Martin TR; Altman LC; Albert RK; Henderson WR
Am Rev Respir Dis; 1984 Jan; 129(1):106-11. PubMed ID: 6322626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
